Mimedx (MDXG) Gross Profit (2011 - 2026)

Mimedx has disclosed Gross Profit across 16 years of filings, most recently posting $41.6 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $41.6 million, down 41.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $315.6 million (up 9.3% YoY), and the FY2025 annual result was $345.6 million, up 19.67% from the prior year.
• Gross Profit came in at $41.6 million for Q1 2026 at Mimedx, down from $99.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $99.0 million in Q4 2025 to a low of $41.6 million in Q1 2026.
• The 5-year median for Gross Profit is $68.7 million (2024), against an average of $68.4 million.
• Across the five-year window, Gross Profit soared 38.22% in 2025 and sank 41.91% in 2026, its largest moves.
• Mimedx's Gross Profit stood at $60.0 million in 2022, then gained by 21.64% to $73.0 million in 2023, then advanced by 4.12% to $76.0 million in 2024, then soared by 30.32% to $99.0 million in 2025, then plunged by 57.97% to $41.6 million in 2026.
• The last three Gross Profit figures came in at $41.6 million (Q1 2026), $99.0 million (Q4 2025), and $95.0 million (Q3 2025), per Business Quant data.